BPC-157 + TB-500 Blend 20mg
BPC-157 / TB-500
CAS: 137525-51-0 / 77591-33-4
Pre-blended vial containing BPC-157 10mg + TB-500 10mg (20mg total). BPC-157 drives angiogenesis and GI mucosal repair via VEGFR2/NO pathways. TB-500 mobilizes actin-binding cell migration. Combined in one vial for convenient recovery stack research. 99.0% HPLC purity.
Specifications
For laboratory research use only. Not for human consumption.
Mechanism of Action
Dual mechanism: BPC-157 stimulates VEGFR2-mediated angiogenesis and nitric oxide production for tissue vascularization. TB-500 sequesters G-actin via LKKTETQ motif to promote cell migration, proliferation, and tissue remodeling.
Research FAQ
Why combine BPC-157 and TB-500?
BPC-157 and TB-500 target tissue repair through different mechanisms. BPC-157 focuses on angiogenesis and GI/tendon repair. TB-500 drives actin-dependent cell migration and anti-inflammatory effects. Together they provide broader multi-tissue coverage.
